Search
for
Sort by
Research 121–150 of 325
- Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Adipokines in the Skin and in Dermatological Diseases
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Poster Presentations
- Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Phytochemicals and Nano-Phytopharmaceuticals Use in Skin, Urogenital and Locomotor Disorders: Are We There?
- Skin manifestations associated with systemic diseases – Part I
- Cosmetic adverse effects of antiseizure medications; A systematic review
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Off-label uses of retinoids in dermatology
- Exploring Pediatric Dermatology in Skin of Color: Focus on Dermoscopy
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Raising awareness of Demodex mites: a neglected cause of skin disease
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- Azelaic acid stimulates catalase activation and promotes hair growth through upregulation of Gli1 and Gli2 mRNA and Shh protein.
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Differential diagnoses of pseudolymphomatous folliculitis: considerations as regards one case
- Potential Cosmetic Applications of Dihydroartemisinin
- Medical Dermatology
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- PA11 A rare case of a severe papulopustular dermatosis secondary to a germline <i>EGFR</i> mutation
- The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Rosacea: I. Etiology, pathogenesis, and subtype classification
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice